101 related articles for article (PubMed ID: 19461185)
1. [Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-year tamoxifen treatment - a case report].
Sakurai T; Umemura T; Jinta E; Suzuma T; Yoshimura G; Shimizu S; Sakurai T
Gan To Kagaku Ryoho; 2009 May; 36(5):819-21. PubMed ID: 19461185
[TBL] [Abstract][Full Text] [Related]
2. [Three cases of metastatic breast cancer, resistant to pre-chemo and/or endocrine therapy, markedly improved with UFT and cyclophosphamide oral combination therapy].
Ogawa Y; Ishikawa T; Ogisawa K; Ikeda K; Nagatsuka I; Matsumura Y; Takashima T; Yashiro M; Onoda N; Nakata B; Kato Y; Hirakawa K
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2123-7. PubMed ID: 11103246
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy for advanced breast cancer: cyclophosphamide, doxorubicin, UFT, and tamoxifen.
Fukuda M; Yamaguchi S; Ohta T; Nakayama Y; Ogata H; Shimizu K; Nishikawa T; Adachi Y; Fukuma E
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):77-81. PubMed ID: 10442369
[TBL] [Abstract][Full Text] [Related]
4. [A case of breast cancer with multiple bone metastases effectively treated with UFT and tamoxifen].
Endo F; Ishii T; Kito T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):851-4. PubMed ID: 2496670
[TBL] [Abstract][Full Text] [Related]
5. [A case of postoperative lung and pleural recurrence after 20 years in a breast cancer patient with marked response to orally administered UFT and cyclophosphamide].
Kusama M; Kaise H; Nakayama S; Oota D; Aoki T; Koyanagi Y; Matsunaga T; Nakamura Y
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1573-6. PubMed ID: 11016004
[TBL] [Abstract][Full Text] [Related]
6. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
7. [A case of recurrent breast cancer with multiple lung metastases responding to anastrozole monotherapy].
Maruyama S; Ito M; Hirano Y; Shimo T; Hashida S; Iga K; Inukai M; Kanaya Y; Yokoyama N
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1787-9. PubMed ID: 18931590
[TBL] [Abstract][Full Text] [Related]
8. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
Hillner BE
Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
[TBL] [Abstract][Full Text] [Related]
9. [A patient with multiple skin metastases from breast cancer responding to S-1 effectively under treatment with trastuzumab].
Tokugawa T; Kobayashi A; Okubo K; Matsuyama T; Imai S; Koyama H
Gan To Kagaku Ryoho; 2009 Apr; 36(4):679-82. PubMed ID: 19381048
[TBL] [Abstract][Full Text] [Related]
10. [Doxifluridine, medroxyprogesterone acetate and cyclophosphamide(DMpC)combination therapy found effective for case of chest wall recurrent breast cancer with bone and pleural metastases].
Kusama M
Gan To Kagaku Ryoho; 2012 Aug; 39(8):1239-41. PubMed ID: 22902449
[TBL] [Abstract][Full Text] [Related]
11. [Safety and compliance with UFT (tegafur and uracil) alone and in combination with hormone therapy in patients with breast cancer].
Taguchi T; Noguchi S
Gan To Kagaku Ryoho; 2009 Sep; 36(9):1465-74. PubMed ID: 19755814
[TBL] [Abstract][Full Text] [Related]
12. [Doxifluridine, medroxyprogesterone acetate and cyclophosphamide (DMpC) combination therapy is effective against recurrent triple negative breast cancer--a case report].
Sakurai T; Umemura T; Jinta E; Suzuma T; Yoshimura G; Shimizu S; Sakurai T
Gan To Kagaku Ryoho; 2008 Dec; 35(13):2433-5. PubMed ID: 19098418
[TBL] [Abstract][Full Text] [Related]
13. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
Howell A; Cuzick J; Baum M; Buzdar A; Dowsett M; Forbes JF; Hoctin-Boes G; Houghton J; Locker GY; Tobias JS;
Lancet; 2005 Jan 1-7; 365(9453):60-2. PubMed ID: 15639680
[TBL] [Abstract][Full Text] [Related]
14. Current and future status of adjuvant therapy for breast cancer.
Coleman RE
Cancer; 2003 Feb; 97(3 Suppl):880-6. PubMed ID: 12548590
[TBL] [Abstract][Full Text] [Related]
15. [Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
Watanabe O; Shimizu T; Imamura H; Kinoshita J; Okabe T; Ogawa K; Haga S
Gan To Kagaku Ryoho; 2004 May; 31(5):717-21. PubMed ID: 15170979
[TBL] [Abstract][Full Text] [Related]
16. [A case of long survival with unresectable duodenal papilla cancer treated with oral chemotherapy using combination UFT and cyclophosphamide].
Mikami R; Nishihara K; Matsunaga H; Abe Y; Mitsuyama S; Nasu T; Yamamoto I; Toyoshima S; Motooka M
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1399-401. PubMed ID: 18701858
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of combination therapy consisting of cyclophosphamide, adriamycin, UFT and oophorectomy/tamoxifen for advanced or recurrent breast cancer].
Kiman K; Suzuki S; Satomi T; Sakonji M; Nihei M; Tanaka T; Kimijima I; Abe R
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2445-52. PubMed ID: 7944490
[TBL] [Abstract][Full Text] [Related]
18. [A case of recurrent breast cancer with carcinomatous pleurisy successfully treated with combined chemoendocrine-therapy of CTF (CPA, THP and 5-FU) and anastrozole following instillation therapy 12 years after radical mastectomy].
Mori K; Chiba N; Yamamoto Y; Yonekawa H
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2565-8. PubMed ID: 12506484
[TBL] [Abstract][Full Text] [Related]
19. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.
Jakesz R; Jonat W; Gnant M; Mittlboeck M; Greil R; Tausch C; Hilfrich J; Kwasny W; Menzel C; Samonigg H; Seifert M; Gademann G; Kaufmann M; Wolfgang J;
Lancet; 2005 Aug 6-12; 366(9484):455-62. PubMed ID: 16084253
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
Smith IE; Dowsett M; Ebbs SR; Dixon JM; Skene A; Blohmer JU; Ashley SE; Francis S; Boeddinghaus I; Walsh G;
J Clin Oncol; 2005 Aug; 23(22):5108-16. PubMed ID: 15998903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
